Siklos

Product manufactured by Medunik

Application Nr Approved Date Route Status External Links
NDA208843 None Oral None Google , Wikipedia , PubMed , DailyMed , Raw OpenFDA , ECHA , ToxNet , JECFA , FAO , 21 CFR

Indications and Purposes

1 Indications And Usage Siklos ® Is Indicated To Reduce The Frequency Of Painful Crises And To Reduce The Need For Blood Transfusions In Pediatric Patients, 2 Years Of Age And Older, With Sickle Cell Anemia With Recurrent Moderate To Severe Painful Crises. Siklos Is An Antimetabolite, Indicated To Reduce The Frequency Of Painful Crises And To Reduce The Need For Blood Transfusions In Pediatric Patients, 2 Years Of Age And Older, With Sickle Cell Anemia With Recurrent Moderate To Severe Painful Crises.

All Formulated Excipients (0 Total)

None

Active Ingredients ( 1 Total)

Name Structure ZINC ID(s)
1. Hydroxyurea HYDROXYUREA ZINC8034120

Comments